221 related articles for article (PubMed ID: 27942931)
41. Different properties of skin of different body sites: The root of keloid formation?
Butzelaar L; Niessen FB; Talhout W; Schooneman DPM; Ulrich MM; Beelen RHJ; Mink van der Molen AB
Wound Repair Regen; 2017 Sep; 25(5):758-766. PubMed ID: 28846161
[TBL] [Abstract][Full Text] [Related]
42. HtrA1 Is Specifically Up-Regulated in Active Keloid Lesions and Stimulates Keloid Development.
Yamawaki S; Naitoh M; Kubota H; Aya R; Katayama Y; Ishiko T; Tamura T; Yoshikawa K; Enoshiri T; Ikeda M; Suzuki S
Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29695130
[TBL] [Abstract][Full Text] [Related]
43. Morphological and immunochemical differences between keloid and hypertrophic scar.
Ehrlich HP; Desmoulière A; Diegelmann RF; Cohen IK; Compton CC; Garner WL; Kapanci Y; Gabbiani G
Am J Pathol; 1994 Jul; 145(1):105-13. PubMed ID: 8030742
[TBL] [Abstract][Full Text] [Related]
44. Reduced hyaluronan in keloid tissue and cultured keloid fibroblasts.
Meyer LJ; Russell SB; Russell JD; Trupin JS; Egbert BM; Shuster S; Stern R
J Invest Dermatol; 2000 May; 114(5):953-9. PubMed ID: 10771477
[TBL] [Abstract][Full Text] [Related]
45. [Keloid scars (part I): Clinical presentation, epidemiology, histology and pathogenesis].
Philandrianos C; Kerfant N; Jaloux C; Martinet L; Bertrand B; Casanova D
Ann Chir Plast Esthet; 2016 Apr; 61(2):128-35. PubMed ID: 26545809
[TBL] [Abstract][Full Text] [Related]
46. Gene expression patterns in isolated keloid fibroblasts.
Satish L; Lyons-Weiler J; Hebda PA; Wells A
Wound Repair Regen; 2006; 14(4):463-70. PubMed ID: 16939575
[TBL] [Abstract][Full Text] [Related]
47. The Communication from Immune Cells to the Fibroblasts in Keloids: Implications for Immunotherapy.
Zhang X; Wu X; Li D
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895153
[TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical Evaluation of Leptin Expression in Wound Healing: A Clue to Exuberant Scar Formation.
Seleit I; Bakry OA; Samaka RM; Tawfik AS
Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):296-306. PubMed ID: 26258753
[TBL] [Abstract][Full Text] [Related]
49. Dasatinib Attenuates Fibrosis in Keloids by Decreasing Senescent Cell Burden.
Darmawan CC; Hur K; Kusumaningrum N; Chung JH; Lee SH; Mun JH
Acta Derm Venereol; 2023 Apr; 103():adv4475. PubMed ID: 37021598
[TBL] [Abstract][Full Text] [Related]
50. Effect of TGF-beta2 on proliferative scar fibroblast cell kinetics.
Polo M; Smith PD; Kim YJ; Wang X; Ko F; Robson MC
Ann Plast Surg; 1999 Aug; 43(2):185-90. PubMed ID: 10454327
[TBL] [Abstract][Full Text] [Related]
51. Monocytes co-cultured with reconstructed keloid and normal skin models skew towards M2 macrophage phenotype.
Limandjaja GC; Waaijman T; Roffel S; Niessen FB; Gibbs S
Arch Dermatol Res; 2019 Oct; 311(8):615-627. PubMed ID: 31187196
[TBL] [Abstract][Full Text] [Related]
52. Effects of botulinum toxin type A on expression of genes in keloid fibroblasts.
Xiaoxue W; Xi C; Zhibo X
Aesthet Surg J; 2014 Jan; 34(1):154-9. PubMed ID: 23709452
[TBL] [Abstract][Full Text] [Related]
53. FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach.
Wu CS; Wu PH; Fang AH; Lan CC
Br J Dermatol; 2012 Sep; 167(3):532-41. PubMed ID: 22540338
[TBL] [Abstract][Full Text] [Related]
54. Notch signaling pathway in keloid disease: enhanced fibroblast activity in a Jagged-1 peptide-dependent manner in lesional vs. extralesional fibroblasts.
Syed F; Bayat A
Wound Repair Regen; 2012; 20(5):688-706. PubMed ID: 22985040
[TBL] [Abstract][Full Text] [Related]
55. Photodynamic therapy on keloid fibroblasts in tissue-engineered keratinocyte-fibroblast co-culture.
Chiu LL; Sun CH; Yeh AT; Torkian B; Karamzadeh A; Tromberg B; Wong BJ
Lasers Surg Med; 2005 Sep; 37(3):231-44. PubMed ID: 16127672
[TBL] [Abstract][Full Text] [Related]
56. Inhibition of Smad3 expression decreases collagen synthesis in keloid disease fibroblasts.
Wang Z; Gao Z; Shi Y; Sun Y; Lin Z; Jiang H; Hou T; Wang Q; Yuan X; Zhu X; Wu H; Jin Y
J Plast Reconstr Aesthet Surg; 2007; 60(11):1193-9. PubMed ID: 17889631
[TBL] [Abstract][Full Text] [Related]
57. DHMEQ, a novel NF-kappaB inhibitor, suppresses growth and type I collagen accumulation in keloid fibroblasts.
Makino S; Mitsutake N; Nakashima M; Saenko VA; Ohtsuru A; Umezawa K; Tanaka K; Hirano A; Yamashita S
J Dermatol Sci; 2008 Sep; 51(3):171-80. PubMed ID: 18406579
[TBL] [Abstract][Full Text] [Related]
58. Growth kinetics and collagen synthesis of normal skin, normal scar and keloid fibroblasts in vitro.
Diegelmann RF; Cohen IK; McCoy BJ
J Cell Physiol; 1979 Feb; 98(2):341-6. PubMed ID: 422662
[TBL] [Abstract][Full Text] [Related]
59. Myofibroblast phenotype and apoptosis in keloid and palmar fibroblasts in vitro.
Chipev CC; Simman R; Hatch G; Katz AE; Siegel DM; Simon M
Cell Death Differ; 2000 Feb; 7(2):166-76. PubMed ID: 10713731
[TBL] [Abstract][Full Text] [Related]
60. Pleiotrophin is downregulated in human keloids.
Lee DH; Jin CL; Kim Y; Shin MH; Kim JE; Kim M; Lee MJ; Cho S
Arch Dermatol Res; 2016 Oct; 308(8):585-91. PubMed ID: 27465069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
